| Dr Matthew S Schwamburger, MD | |
|
1805 27th St, Portsmouth, OH 45662-2640 | |
| (740) 356-5000 | |
| Not Available |
| Full Name | Dr Matthew S Schwamburger |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 21 Years |
| Location | 1805 27th St, Portsmouth, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457552119 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 35089860 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southern Ohio Medical Center | Portsmouth, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Somc Medical Care Foundation, Inc. | 9436061645 | 215 |
News Archive
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ failure, announced today that its lead clinical candidate STX-100 has been granted orphan drug status by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis, a debilitating and almost uniformly fatal disease in which patients experience progressive difficulty breathing due to fibrosis (scarring) of the lung.
A research team at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown in a study that two closely related enzymes could be targets for the treatment of lung cancer. The discovery was made when the researchers blocked the production of the two enzymes in transgenic mice. This resulted in inhibition of cell growth, fewer tumours and greater survival among the mice.
The Commission on Cancer, a national consortium of organizations dedicated to improving survival rates and quality of life for cancer patients, has recognized Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute as one of nation's foremost cancer programs.
Higher flu vaccination rates for health care personnel can dramatically reduce the threat of flu outbreak among nursing home residents, according to a study published in the October issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
Chinese men are putting their wives at increased risk of long-term illness and early death by smoking, finds a study in this week's British Medical Journal.
› Verified 3 days ago
| Entity Name | Somc Medical Care Foundation, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457467227 PECOS PAC ID: 9436061645 Enrollment ID: O20031125000203 |
News Archive
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ failure, announced today that its lead clinical candidate STX-100 has been granted orphan drug status by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis, a debilitating and almost uniformly fatal disease in which patients experience progressive difficulty breathing due to fibrosis (scarring) of the lung.
A research team at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown in a study that two closely related enzymes could be targets for the treatment of lung cancer. The discovery was made when the researchers blocked the production of the two enzymes in transgenic mice. This resulted in inhibition of cell growth, fewer tumours and greater survival among the mice.
The Commission on Cancer, a national consortium of organizations dedicated to improving survival rates and quality of life for cancer patients, has recognized Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute as one of nation's foremost cancer programs.
Higher flu vaccination rates for health care personnel can dramatically reduce the threat of flu outbreak among nursing home residents, according to a study published in the October issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
Chinese men are putting their wives at increased risk of long-term illness and early death by smoking, finds a study in this week's British Medical Journal.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew S Schwamburger, MD 1735 27th St Ste B06, Portsmouth, OH 45662-2681 Ph: (740) 356-8681 | Dr Matthew S Schwamburger, MD 1805 27th St, Portsmouth, OH 45662-2640 Ph: (740) 356-5000 |
News Archive
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ failure, announced today that its lead clinical candidate STX-100 has been granted orphan drug status by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis, a debilitating and almost uniformly fatal disease in which patients experience progressive difficulty breathing due to fibrosis (scarring) of the lung.
A research team at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown in a study that two closely related enzymes could be targets for the treatment of lung cancer. The discovery was made when the researchers blocked the production of the two enzymes in transgenic mice. This resulted in inhibition of cell growth, fewer tumours and greater survival among the mice.
The Commission on Cancer, a national consortium of organizations dedicated to improving survival rates and quality of life for cancer patients, has recognized Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute as one of nation's foremost cancer programs.
Higher flu vaccination rates for health care personnel can dramatically reduce the threat of flu outbreak among nursing home residents, according to a study published in the October issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
Chinese men are putting their wives at increased risk of long-term illness and early death by smoking, finds a study in this week's British Medical Journal.
› Verified 3 days ago
Dr. Javaid A Malik, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1711 27th St Ste 103, Portsmouth, OH 45662 Phone: 740-356-6740 Fax: 740-355-9281 | |
Thomas Robert Smith, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1805 27th St, Portsmouth, OH 45662 Phone: 740-356-5000 | |
Jaime M Pua, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1805 27th St, Portsmouth, OH 45662 Phone: 740-356-5000 | |
Dr. Joseph W Lucero, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2001 Scioto Trl, King's Daughters Medical Center Ohio, Portsmouth, OH 45662 Phone: 740-991-4000 | |
Dr. Luis F Benitez Lopez, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1805 27th St, Portsmouth, OH 45662 Phone: 740-356-8231 Fax: 740-356-3686 | |
Dr. Andrew M. Sopchak, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1805 27th St, Portsmouth, OH 45662 Phone: 740-356-8681 Fax: 740-353-7900 | |
Eric P Macdonald, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1805 27th St, Portsmouth, OH 45662 Phone: 740-356-5000 |